{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T04:11:45Z","timestamp":1750911105211,"version":"3.41.0"},"reference-count":71,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:p>Lack of success in ovarian cancer control through screening or advances in treatment in the general population has prompted exploration in new avenues of prevention. \u201cOpportunistic\u201d salpingectomy describes a surgical procedure or risk-reducing intent in women at low-risk\/general population risk for developing ovarian cancer who are undergoing pelvic\/abdominal surgery for other indications. This chapter reviews the uptake, safety, and anticipated impact of this prevention initiative.<\/jats:p>","DOI":"10.1097\/grf.0000000000000315","type":"journal-article","created":{"date-parts":[[2017,9,28]],"date-time":"2017-09-28T23:38:21Z","timestamp":1506641901000},"page":"758-770","source":"Crossref","is-referenced-by-count":6,"title":["Risk-reducing Surgery in Women at Low Lifetime Risk of Developing Ovarian Carcinoma: Opportunistic Salpingectomy"],"prefix":"10.1097","volume":"60","author":[{"given":"GILLIAN E.","family":"HANLEY","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NIRIT M.K.","family":"ROZENBERG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JESSICA N.","family":"MCALPINE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230911","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1371\/journal.pmed.0050232","article-title":"Ovarian carcinoma subtypes are different diseases: implications for biomarker studies","volume":"5","author":"Kobel","year":"2008","journal-title":"PLoS Med"},{"key":"R2-20230911","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/PGP.0b013e3181c042b6","article-title":"Differences in tumor type in low-stage versus high-stage ovarian carcinomas","volume":"29","author":"Kobel","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"R3-20230911","first-page":"296","article-title":"The role of the fallopian tube in ovarian cancer","volume":"10","author":"Tone","year":"2012","journal-title":"Clin Adv Hematol Oncol"},{"key":"R4-20230911","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1097\/01.AOG.0000466373.71146.51","article-title":"ACOG Practice Bulletin No. 634. Hereditary cancer syndromes and risk assessment. Committee Opinion","volume":"125","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R5-20230911","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1097\/IGC.0000000000000235","article-title":"Pelvic inflammation and the pathogenesis of ovarian cancer: a cohort study","volume":"24","author":"McAlpine","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"R6-20230911","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1158\/1055-9965.EPI-16-0459","article-title":"Is pelvic inflammatory disease a risk factor for ovarian cancer?","volume":"26","author":"Rasmussen","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R7-20230911","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.fertnstert.2004.03.013","article-title":"Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control study","volume":"82","author":"Pike","year":"2004","journal-title":"Fertil Steril"},{"key":"R8-20230911","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls","volume":"371","author":"Beral","year":"2008","journal-title":"Lancet"},{"key":"R9-20230911"},{"key":"R10-20230911","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(15)01224-6","article-title":"Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial","volume":"387","author":"Jacobs","year":"2015","journal-title":"Lancet"},{"key":"R11-20230911","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1001\/jama.2011.766","article-title":"Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial","volume":"305","author":"Buys","year":"2011","journal-title":"JAMA"},{"key":"R12-20230911","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1525-1438.2007.01035.x","article-title":"A randomized study of screening for ovarian cancer: a multicenter study in Japan","volume":"18","author":"Kobayashi","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"R13-20230911","article-title":"U.S. Preventive Services Task Force. 2017. Available at:"},{"key":"R14-20230911","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ygyno.2005.08.038","article-title":"CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer","volume":"100","author":"Olivier","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R15-20230911","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1111\/j.1471-0528.2007.01499.x","article-title":"Annual surveillance by CA125 and transvaginal ultrasound for ovarian cancer in both high-risk and population risk women is ineffective","volume":"114","author":"Woodward","year":"2007","journal-title":"BJOG"},{"key":"R16-20230911","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7326\/M13-2747","article-title":"Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: US Preventive Services Task Force recommendation statement","volume":"160","author":"Moyer","year":"2014","journal-title":"Ann Intern Med"},{"key":"R17-20230911","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00006250-200801000-00039","article-title":"ACOG Practice Bulletin No. 89. Elective and risk-reducing salpingo-oophorectomy","volume":"111","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R18-20230911","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/AOG.0b013e3182864350","article-title":"Long-term mortality associated with oophorectomy compared with ovarian conservation in the nurses\u2019 health study","volume":"121","author":"Parker","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R19-20230911","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1093\/humrep\/der274","article-title":"The post-reproductive Fallopian tube: better removed?","volume":"26","author":"Dietl","year":"2011","journal-title":"Hum Reprod"},{"key":"R20-20230911","doi-asserted-by":"crossref","first-page":"e1000114","DOI":"10.1371\/journal.pmed.1000114","article-title":"The preclinical natural history of serous ovarian cancer: defining the target for early detection","volume":"6","author":"Brown","year":"2009","journal-title":"PLoS Med"},{"key":"R21-20230911","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"R22-20230911","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/pon.2041","article-title":"The impact of prophylactic salpingo-oophorectomy on quality of life and psychological distress in women with a BRCA mutation","volume":"22","author":"Finch","year":"2013","journal-title":"Psychooncology"},{"key":"R23-20230911","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.2013.53.2820","article-title":"Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation","volume":"32","author":"Finch","year":"2014","journal-title":"J Clin Oncol"},{"key":"R24-20230911","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/AOG.0b013e3182783c2f","article-title":"Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers","volume":"121","author":"Kwon","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R25-20230911","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ajog.2014.01.003","article-title":"Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention","volume":"210","author":"McAlpine","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"R26-20230911","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3747\/co.20.1560","article-title":"Examining the use of salpingectomy with hysterectomy in Canada","volume":"20","author":"Sandoval","year":"2013","journal-title":"Curr Oncol"},{"key":"R27-20230911"},{"key":"R28-20230911"},{"key":"R29-20230911","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/01.AOG.0000459871.88564.09","article-title":"Committee opinion no. 620: salpingectomy for ovarian cancer prevention","volume":"125","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R30-20230911","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/ajo.12402","article-title":"Opportunistic bilateral salpingectomy during gynaecological surgery for benign disease: a survey of current Australian practice","volume":"55","author":"Kapurubandara","year":"2015","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R31-20230911","first-page":"1332","article-title":"Prophylactic bilateral salpingectomy for the prevention of ovarian cancers: What is happening in Italy?","volume":"104","author":"Venturella","year":"2015","journal-title":"Eur J Cancer Prev"},{"key":"R32-20230911","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/GME.0000000000000211","article-title":"Oophorectomy versus salpingectomy: a convergence of ideas","volume":"21","author":"Parker","year":"2014","journal-title":"Menopause"},{"key":"R33-20230911","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1701-2163(15)30894-X","article-title":"Risk-reducing salpingectomy in Canada: a survey of obstetrician-gynaecologists","volume":"35","author":"Reade","year":"2013","journal-title":"J Obstet Gynaecol Can"},{"key":"R34-20230911","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jmig.2013.02.010","article-title":"Physician opinions regarding elective bilateral salpingectomy with hysterectomy and for sterilization","volume":"20","author":"Gill","year":"2013","journal-title":"J Minim Invasive Gynecol"},{"key":"R35-20230911","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejogrb.2013.06.030","article-title":"Opportunistic and interventional salpingectomy in women at risk: a strategy for preventing pelvic serous cancer (PSC)","volume":"170","author":"Kamran","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"author":"Tamussino K","key":"R36-20230911","article-title":"What do women scheduled for laparoscopic cholecystectom think about potential prophylactic salpingectomy? 16th Biennial Meeting of the International Gynecologic Cancer Society-Abstracts"},{"key":"R37-20230911","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ajog.2016.07.055","article-title":"Growth in salpingectomy rates in the United States since 2000","volume":"215","author":"Hicks-Courant","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R38-20230911","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ajog.2015.04.031","article-title":"National trends of adnexal surgeries at the time of hysterectomy for benign indication, United States, 1998-2011","volume":"213","author":"Mikhail","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"R39-20230911","first-page":"270","article-title":"The performance and safety of bilateral salpingectomy for ovarian cancer prevention in the United States","volume":"216","author":"Hanley","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"R40-20230911","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.jmig.2016.07.009","article-title":"Trends of bilateral salpingectomy during vaginal hysterectomy with and without laparoscopic assistance performed for benign indications in the United States","volume":"23","author":"Mikhail","year":"2016","journal-title":"J Minim Invasive Gynecol"},{"key":"R41-20230911","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/AOG.0000000000001531","article-title":"Experience with opportunistic salpingectomy in a large, community-based health system in the United States","volume":"128","author":"Garcia","year":"2016","journal-title":"Obstet Gynecol"},{"key":"R42-20230911","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1055\/s-0042-116493","article-title":"Incidental (prophylactic) salpingectomy at benign gynecologic surgery and cesarean section: a survey of practice in Austria","volume":"76","author":"Potz","year":"2016","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"R43-20230911","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.suronc.2015.09.008","article-title":"Prophylactic salpingectomy and prophylactic salpingoophorectomy for adnexal high-grade serous epithelial carcinoma: a reappraisal","volume":"24","author":"Oliver Perez","year":"2015","journal-title":"Surg Oncol"},{"key":"R44-20230911","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00404-015-3697-y","article-title":"Opportunistic salpingectomies for the prevention of a high-grade serous carcinoma: a statement by the Kommission Ovar of the AGO","volume":"292","author":"Polcher","year":"2015","journal-title":"Arch Gynecol Obstet"},{"key":"R45-20230911","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/IGC.0000000000000567","article-title":"Should opportunistic bilateral salpingectomy (OBS) for prevention of ovarian cancer be incorporated into routine care or offered in the context of a clinical trial?","volume":"26","author":"Manchanda","year":"2016","journal-title":"Int J Gynecol Cancer"},{"key":"R46-20230911","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/1471-0528.13741","article-title":"Opportunistic bilateral salpingectomy (OBS) for the prevention of ovarian cancer should be offered in the context of a clinical trial: FOR: There is lack of clarity on a number of key issues","volume":"123","author":"Manchanda","year":"2016","journal-title":"BJOG"},{"key":"R47-20230911","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/1471-0528.13742","article-title":"Opportunistic salpingectomy at benign gynaecological surgery for ovarian cancer prevention should be performed within a clinical trial: AGAINST: can we afford to wait for the results?","volume":"123","author":"Kehoe","year":"2016","journal-title":"BJOG"},{"key":"R48-20230911","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/GCO.0000000000000204","article-title":"Role of salpingectomy at the time of urogynecologic surgery","volume":"27","author":"Bradley","year":"2015","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R49-20230911","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/j.fertnstert.2013.07.1997","article-title":"Short-term effects of salpingectomy during laparoscopic hysterectomy on ovarian reserve: a pilot randomized controlled trial","volume":"100","author":"Findley","year":"2013","journal-title":"Fertil Steril"},{"key":"R50-20230911","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ygyno.2013.03.023","article-title":"Prophylactic salpingectomy in premenopausal low-risk women for ovarian cancer: primum non nocere","volume":"129","author":"Morelli","year":"2013","journal-title":"Gynecol Oncol"},{"key":"R51-20230911","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.fertnstert.2015.08.004","article-title":"Wide excision of soft tissues adjacent to the ovary and fallopian tube does not impair the ovarian reserve in women undergoing prophylactic bilateral salpingectomy: results from a randomized, controlled trial","volume":"104","author":"Venturella","year":"2015","journal-title":"Fertil Steril"},{"key":"R52-20230911","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jmig.2016.08.833","article-title":"3 to 5 years later: long-term effects of prophylactic bilateral salpingectomy on ovarian function","volume":"24","author":"Venturella","year":"2017","journal-title":"J Minim Invasive Gynecol"},{"key":"R53-20230911","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.fertnstert.2016.05.030","article-title":"Does salpingectomy have a deleterious impact on ovarian response in in vitro fertilization cycles?","volume":"106","author":"Yoon","year":"2016","journal-title":"Fertil Steril"},{"key":"R54-20230911","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jmig.2015.01.025","article-title":"Comparing the effect of laparoscopic supracervical and total hysterectomy for uterine fibroids on ovarian reserve by assessing serum anti-mullerian hormone levels: a prospective cohort study","volume":"22","author":"Yuan","year":"2015","journal-title":"J Minim Invasive Gynecol"},{"key":"R55-20230911","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ejogrb.2013.09.043","article-title":"Comparison of serum anti-Mullerian hormone levels following hysterectomy and myomectomy for benign gynaecological conditions","volume":"171","author":"Wang","year":"2013","journal-title":"Eur J Obstet, Gynecol Reprod Biol"},{"key":"R56-20230911","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/IGC.0000000000000567","article-title":"Should opportunistic bilateral salpingectomy (obs) for prevention of ovarian cancer be incorporated into routine care or offered in the context of a clinical trial?","volume":"26","author":"Manchanda","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"R57-20230911","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00432-014-1622-6","article-title":"Prophylactic bilateral salpingectomy (PBS) to reduce ovarian cancer risk incorporated in standard premenopausal hysterectomy: complications and re-operation rate","volume":"140","author":"Vorwergk","year":"2014","journal-title":"J Cancer Res Clin Oncol"},{"key":"R58-20230911","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.jmig.2015.04.012","article-title":"Success and complications of salpingectomy at the time of vaginal hysterectomy","volume":"22","author":"Robert","year":"2015","journal-title":"J Minim Invasive Gynecol"},{"key":"R59-20230911","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/AOG.0000000000000630","article-title":"Costs and benefits of opportunistic salpingectomy as an ovarian cancer prevention strategy","volume":"125","author":"Kwon","year":"2015","journal-title":"Obstet Gynecol"},{"key":"R60-20230911","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/ije\/dyt042","article-title":"Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies","volume":"42","author":"Sieh","year":"2013","journal-title":"Int J Epidemiol"},{"key":"R61-20230911","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1757-2215-5-13","article-title":"Tubal ligation, hysterectomy and ovarian cancer: a meta-analysis","volume":"5","author":"Rice","year":"2012","journal-title":"J Ovarian Res"},{"key":"R62-20230911","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(00)04642-0","article-title":"Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study","volume":"357","author":"Narod","year":"2001","journal-title":"Lancet"},{"key":"R63-20230911","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/bjc.2016.80","article-title":"Tubal ligation and incidence of 26 site-specific cancers in the Million Women Study","volume":"114","author":"Gaitskell","year":"2016","journal-title":"Br J Cancer"},{"key":"R64-20230911","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/ijc.29856","article-title":"Tubal ligation and ovarian cancer risk in a large cohort: substantial variation by histological type","volume":"138","author":"Gaitskell","year":"2016","journal-title":"Int J Cancer"},{"key":"R65-20230911","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ygyno.2014.10.005","article-title":"Effect of tubal sterilization technique on risk of serous epithelial ovarian and primary peritoneal carcinoma","volume":"135","author":"Lessard-Anderson","year":"2014","journal-title":"Gynecol Oncol"},{"key":"R66-20230911","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/aogs.12516","article-title":"Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study","volume":"94","author":"Madsen","year":"2015","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R67-20230911","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju410","article-title":"Ovarian cancer risk after salpingectomy: a nationwide population-based study","volume":"107","author":"Falconer","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"R68-20230911","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jogc.2016.04.084","article-title":"Opportunistic salpingectomy: we chose to act, not wait","volume":"38","author":"McAlpine","year":"2016","journal-title":"J Obstet Gynaecol Can"},{"key":"R69-20230911","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.urolonc.2015.05.011","article-title":"The effect of surgical duration of transurethral resection of bladder tumors on postoperative complications: an analysis of ACS NSQIP data","volume":"33","author":"Matulewicz","year":"2015","journal-title":"Urol Oncol"},{"key":"R70-20230911","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.jmig.2015.05.022","article-title":"Longer operative time during benign laparoscopic and robotic hysterectomy is associated with increased 30-day perioperative complications","volume":"22","author":"Catanzarite","year":"2015","journal-title":"J Minim Invasive Gynecol"},{"key":"R71-20230911","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijsu.2015.05.051","article-title":"Surgical duration and risk of urinary tract infection: an analysis of 1,452,369 patients using the National Surgical Quality Improvement Program (NSQIP)","volume":"20","author":"Qin","year":"2015","journal-title":"Int J Surg"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003081-201712000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T22:55:33Z","timestamp":1750892133000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003081-201712000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":71,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0000000000000315","relation":{},"ISSN":["0009-9201"],"issn-type":[{"type":"print","value":"0009-9201"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}